Advance scientific discoveries with our comprehensive suite of preclinical services, including iPSC solutions, Genome Editing, In Vitro Assays, and more. Explore our extensive range of human and animal primary cells, iPSCs, and customizable models for disease research.
Discover our extensive collection of Human and Animal Cells, Clinical and Patient-Derived models. Trusted by researchers and scientists worldwide, our cells are consistently cited in research publications, attesting their quality and dependability.
We offer iPSC reprogramming, Cas9 genome editing, directed differentiation, custom cell isolation, in vitro assays, and ASO screening services. Our team of PhD scientists provides disease-relevant, patent-derived models that accelerate drug discovery and disease understanding.
We specialize in complex assay development and execution for research support. Our expertise includes multi-cellular model building, 3D liver model signaling studies, and compound screening for iPSC-derived neurons and human immune cells.
Stay updated with the latest scientific discoveries, innovations, and breakthroughs: company news, industry insights, and events.
Connect. Inspire. Learn Every year, Global Genes organizes one of the world’s largest gatherings for
IXCELLS BIOTECHNOLOGIES EXPANDS OPERATIONS; NEW WEBSITE GOES LIVE Increased operational capacity positions company for continued
Gene Editing Services Deliver Disease Relevant Cell Models to Improve Preclinical Drug Development May 16,
We’re thrilled to announce that iXCells will be exhibiting at the upcoming Immunology 2023 conference